Literature DB >> 7356679

Enterohepatic physiology of 1,25-dihydroxyvitamin D3.

R Kumar, S Nagubandi, V R Mattox, J M Londowski.   

Abstract

After intravenous administration of radiolabeled 1,25-dihydroxyvitamin D3 to rats, approximately 25% of the administered radioactivity appeared in the bile within 24 h. Instillation of the biliary radioactivity into the duodena of other rats was followed by recovery of 15% of the radioactivity in newly secreted bile within 24 h. The process by which products of 1,25-dihydroxyvitamin D3 were excreted in bile was not saturable in the dose range tested (0.275-650 ng). The metabolites of 1,25-dihydroxyvitamin D3 present in bile were found to be much more polar than 1,25-dihydroxyvitamin D3 and were resolved into three fractions on high performance liquid chromatography. 60% of the radioactivity present in bile was retained selectively by DEAE-cellulose; the radioactive material could be eluted from the gel at a low pH or at high salt concentrations. When bile containing the radiolabeled metabolites was incubated at 37 degrees C and pH 5 with beta-glucuronidase, there was an increase in the amount of radioactivity comigrating with 1,25-dihydroxyvitamin D3. Treatment of the products of radiolabeled 1,25-dihydroxyvitamin D3 in bile with diazomethane, an agent which converts acids into methyl esters, transformed one of the metabolites into a less polar compound. These results demonstrate that there is a quantitatively important enterophepatic circulation of the products of 1,25-dihydroxyvitamin D3 in the rat.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7356679      PMCID: PMC371364          DOI: 10.1172/JCI109669

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Glucuronidation of 3 alpha-hydroxysteroids in vitro.

Authors:  G L Carlson; V R Mattox
Journal:  J Steroid Biochem       Date:  1979-02       Impact factor: 4.292

2.  Side chain oxidation of 25-hydroxy-[26,27-14C]vitamin D3 and 1,25-dihydroxy-[26,27-14C]vitamin D3 in vivo by chickens.

Authors:  R Kumar; H F DeLuca
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

3.  The effect of various anaesthetic techniques on the flow rate, constituents and enzymic composition of rat bile.

Authors:  B Cooper; M N Eakins; T F Slater
Journal:  Biochem Pharmacol       Date:  1976-08-01       Impact factor: 5.858

4.  Side chain metabolism of 25-hydroxy-[26,27-14C] vitamin D3 and 1,25-dihydroxy-[26,27-14C] vitamin D3 in vivo.

Authors:  D Harnden; R Kumar; M F Holick; H F Deluca
Journal:  Science       Date:  1976-08-06       Impact factor: 47.728

5.  25-Hydroxycholecalciferol-1-hydroxylase. Subcellular location and properties.

Authors:  R W Gray; J L Omdahl; J G Ghazarian; H F DeLuca
Journal:  J Biol Chem       Date:  1972-12-10       Impact factor: 5.157

6.  25-Hydroxyvitamin D3: evidence of an enterohepatic circulation in man.

Authors:  S B Arnaud; R S Goldsmith; P W Lambert; V L Go
Journal:  Proc Soc Exp Biol Med       Date:  1975-06

7.  Rat intestinal 25-hydroxyvitamin D3- and 1alpha,25-dihydroxyvitamin D3-24-hydroxylase.

Authors:  R Kumar; H K Schnoes; H F DeLuca
Journal:  J Biol Chem       Date:  1978-06-10       Impact factor: 5.157

8.  Metabolism of vitamin D3-3H in human subjects: distribution in blood, bile, feces, and urine.

Authors:  L V Avioli; S W Lee; J E McDonald; J Lund; H F DeLuca
Journal:  J Clin Invest       Date:  1967-06       Impact factor: 14.808

9.  Investigations on metabolites of vitamin D in rat bile. Separation and partial identification of a major metabolite.

Authors:  P A Bell; E Kodicek
Journal:  Biochem J       Date:  1969-12       Impact factor: 3.857

10.  Metabolism and excretion of 3H-1,25-(OH)2-vitamin D3 in healthy adults.

Authors:  R W Gray; A E Caldas; D R Wilz; J Lemann; G A Smith; H F DeLuca
Journal:  J Clin Endocrinol Metab       Date:  1978-05       Impact factor: 5.958

View more
  17 in total

Review 1.  Vitamin D-endocrine system.

Authors:  N H Bell
Journal:  J Clin Invest       Date:  1985-07       Impact factor: 14.808

Review 2.  Vitamin D and the kidney.

Authors:  Rajiv Kumar; Peter J Tebben; James R Thompson
Journal:  Arch Biochem Biophys       Date:  2012-03-15       Impact factor: 4.013

3.  Importance of apical membrane delivery of 1,25-dihydroxyvitamin D3 to vitamin D-responsive gene expression in the colon.

Authors:  Nicholas J Koszewski; Ronald L Horst; Jesse P Goff
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-07-26       Impact factor: 4.052

Review 4.  Vitamin D-Mediated Hypercalcemia: Mechanisms, Diagnosis, and Treatment.

Authors:  Peter J Tebben; Ravinder J Singh; Rajiv Kumar
Journal:  Endocr Rev       Date:  2016-09-02       Impact factor: 19.871

5.  1,25 dihydroxyvitamin D-induced inhibition of 3H-25 hydroxyvitamin D production by the rachitic rat liver in vitro.

Authors:  D T Baran; M L Milne
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

6.  Do tissues other than the kidney produce 1,25-dihydroxyvitamin D3 in vivo? A reexamination.

Authors:  T D Shultz; J Fox; H Heath; R Kumar
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

7.  Role of vitamin D glucosiduronate in calcium homeostasis.

Authors:  S Nagubandi; R Kumar; J M Londowski; R A Corradino; P S Tietz
Journal:  J Clin Invest       Date:  1980-12       Impact factor: 14.808

Review 8.  Interplay between vitamin D and the drug metabolizing enzyme CYP3A4.

Authors:  Zhican Wang; Erin G Schuetz; Yang Xu; Kenneth E Thummel
Journal:  J Steroid Biochem Mol Biol       Date:  2012-09-15       Impact factor: 4.292

9.  Biliary excretion of radioactivity after intravenous administration of 3H-1,25-dihydroxyvitamin D3 in man.

Authors:  J E Ledger; G J Watson; C C Ainley; J E Compston
Journal:  Gut       Date:  1985-11       Impact factor: 23.059

Review 10.  Bile formation and secretion.

Authors:  James L Boyer
Journal:  Compr Physiol       Date:  2013-07       Impact factor: 9.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.